Literature DB >> 33201461

Known Inhibitors of RNA Helicases and Their Therapeutic Potential.

Yosser Zina Abdelkrim1,2, Josette Banroques1,3, N Kyle Tanner4.   

Abstract

RNA helicases are proteins found in all kingdoms of life, and they are associated with all processes involving RNA from transcription to decay. They use NTP binding and hydrolysis to unwind duplexes, to remodel RNA structures and protein-RNA complexes, and to facilitate the unidirectional metabolism of biological processes. Viral, bacterial, and eukaryotic parasites have an intimate need for RNA helicases in their reproduction. Moreover, various disorders, like cancers, are often associated with a perturbation of the host's helicase activity. Thus, RNA helicases provide a rich source of targets for the development of therapeutic or prophylactic drugs. In this review, we provide an overview of the different targeting strategies against helicases, the different types of compounds explored, the proposed inhibitory mechanisms of the compounds on the proteins, and the therapeutic potential of these compounds in the treatment of various disorders.

Entities:  

Keywords:  Aminocholestanol; DDX2; DDX3; DExD/H-box; Hippuristanol; Interface inhibitor; NS3; Pateamine A; Ring-expanded nucleosides; Rocaglamide

Mesh:

Substances:

Year:  2021        PMID: 33201461     DOI: 10.1007/978-1-0716-0935-4_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  A scalable framework for the discovery of functional helicase substrates and helicase-driven regulatory switches.

Authors:  Mildred Delaleau; Eric Eveno; Isabelle Simon; Annie Schwartz; Marc Boudvillain
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-12       Impact factor: 12.779

2.  The In Silico Identification of Potential Members of the Ded1/DDX3 Subfamily of DEAD-Box RNA Helicases from the Protozoan Parasite Leishmania infantum and Their Analyses in Yeast.

Authors:  Molka Mokdadi; Yosser Zina Abdelkrim; Josette Banroques; Emmeline Huvelle; Rafeh Oualha; Hilal Yeter-Alat; Ikram Guizani; Mourad Barhoumi; N Kyle Tanner
Journal:  Genes (Basel)       Date:  2021-02-01       Impact factor: 4.096

3.  Enzymatic and Molecular Characterization of Anti-Leishmania Molecules That Differently Target Leishmania and Mammalian eIF4A Proteins, LieIF4A and eIF4AMus.

Authors:  Yosser Zina Abdelkrim; Emna Harigua-Souiai; Imen Bassoumi-Jamoussi; Mourad Barhoumi; Josette Banroques; Khadija Essafi-Benkhadir; Michael Nilges; Arnaud Blondel; N Kyle Tanner; Ikram Guizani
Journal:  Molecules       Date:  2022-09-10       Impact factor: 4.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.